| 31 | Ep136: Deborah Palestrant on Building Biotech Startups 2023-05-30 |
Play |
| 32 | Ep135: John Maraganore on Developing a New Class of Medicines 2023-05-08 |
Play |
| 33 | Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies 2023-04-24 |
Play |
| 34 | Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies 2023-04-12 |
Play |
| 35 | Ep132: Eric Dobmeier on Treating Kidney Disease 2023-03-28 |
Play |
| 36 | Ep131: Ryan Watts on Neuroscience Drug R&D 2023-03-14 |
Play |
| 37 | Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave 2023-02-28 |
Play |
| 38 | Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies 2023-02-14 |
Play |
| 39 | Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last 2023-02-01 |
Play |
| 40 | Ep127: Jeb Keiper on Computational Drug Discovery 2023-01-20 |
Play |
The Long Run with Luke Timmerman
https://feeds.soundcloud.com/users/soundcloud:users:317770704/sounds.rss
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
